Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ginsberg, J. P.
Right arrow Articles by Barr, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ginsberg, J. P.
Right arrow Articles by Barr, F. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 17, Issue 6 (June), 1999: 1809
© 1999 American Society for Clinical Oncology

EWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma

Jill P. Ginsberg, Enrique de Alava, Marc Ladanyi, Leonard H. Wexler, Heinrich Kovar, Michael Paulussen, Andreas Zoubek, Barbara Dockhorn-Dworniczak, Herbert Juergens, Jay S. Wunder, Irene L. Andrulis, Rajesh Malik, Poul H.B. Sorensen, Richard B. Womer, Frederic G. Barr

From the The Children's Hospital of Philadelphia, Philadelphia; University of Pennsylvania School of Medicine, Philadelphia, PA; Clinica Universitaria de Navarra, Pamplona, Spain; Memorial Sloan-Kettering Cancer Center, New York; Columbia University College of Physicians and Surgeons, New York, NY; Children's Cancer Research Institute, St. Anna Children's Hospital, Vienna, Austria; Department of Pediatric Hematology and Oncology, and Gerhard Domagk Institute of Pathology, Westfaehlische Wilhelms University, Muenster, Germany; University of Virginia, Charlottesville, VA; Mount Sinai Hospital, Toronto, ON, Canada; and British Columbia's, Canada Children's Hospital, Vancouver, BC, Canada.

Address reprint requests to Frederic G. Barr, MD, PhD, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 36th and Hamilton Walk, Philadelphia, PA 19104-6082; email barrfg{at}mail.med.upenn.edu

PURPOSE: There are a variety of solid tumors in which alternative chromosomal translocations generate related fusion products. In alveolar rhabdomyosarcoma and synovial sarcoma, these variant fusions have been found to have major clinical significance. We investigated whether the two alternative gene fusion products, EWS-FLI1 and EWS-ERG, define different clinical subsets within the Ewing's sarcoma family of tumors.

PATIENTS AND METHODS: We selected 30 cases of Ewing's sarcoma with the EWS-ERG gene fusion and 106 cases with the EWS-FLI1 fusion. Clinical data were obtained for each case and compared with the molecular diagnostic findings.

RESULTS: There were no significant clinical differences observed between the two groups in age of diagnosis, sex, metastasis at diagnosis, primary site, event-free survival, or overall survival.

CONCLUSION: Differences in the C-terminal partner in the Ewing's sarcoma family gene fusions are not associated with significant phenotypic differences.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Kruse, S. J. Loughran, T. M. Baldwin, E. C. Josefsson, S. Ellis, D. K. Watson, P. Nurden, D. Metcalf, D. J. Hilton, W. S. Alexander, et al.
Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage
PNAS, August 18, 2009; 106(33): 13814 - 13819.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
O. Slater and J. Shipley
Clinical relevance of molecular genetics to paediatric sarcomas
J. Clin. Pathol., November 1, 2007; 60(11): 1187 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. L. Ng, M. J. O'Sullivan, C. J. Pallen, M. Hayes, P. W. Clarkson, M. Winstanley, P. H.B. Sorensen, T. O. Nielsen, and D. E. Horsman
Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEV
J. Mol. Diagn., September 1, 2007; 9(4): 459 - 463.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
F. G. Barr and R. B. Womer
Molecular Diagnosis of Ewing Family Tumors: Too Many Fusions... ?
J. Mol. Diagn., September 1, 2007; 9(4): 437 - 440.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
L. Wang, R. Bhargava, T. Zheng, L. Wexler, M. H. Collins, D. Roulston, and M. Ladanyi
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions: Identification of a Novel EWS-SP3 Fusion and of Additional Cases with the EWS-ETV1 and EWS-FEV Fusions
J. Mol. Diagn., September 1, 2007; 9(4): 498 - 509.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Iwamoto
Diagnosis and Treatment of Ewing's Sarcoma
Jpn. J. Clin. Oncol., February 1, 2007; 37(2): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Scurr and I. Judson
How to Treat the Ewing's Family of Sarcomas in Adult Patients
Oncologist, January 1, 2006; 11(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Rainis, T. Toki, J. E. Pimanda, E. Rosenthal, K. Machol, S. Strehl, B. Gottgens, E. Ito, and S. Izraeli
The Proto-Oncogene ERG in Megakaryoblastic Leukemias
Cancer Res., September 1, 2005; 65(17): 7596 - 7602.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.-Y. Huang, P. B. Illei, Z. Zhao, M. Mazumdar, A. G. Huvos, J. H. Healey, L. H. Wexler, R. Gorlick, P. Meyers, and M. Ladanyi
Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse
J. Clin. Oncol., January 20, 2005; 23(3): 548 - 558.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. M. Oliveira and C. D.M. Fletcher
Molecular Prognostication for Soft Tissue Sarcomas: Are We Ready Yet?
J. Clin. Oncol., October 15, 2004; 22(20): 4031 - 4034.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Matsui, H. A. Chansky, F. Barahmand-Pour, A. Zielinska-Kwiatkowska, N. Tsumaki, A. Myoui, H. Yoshikawa, L. Yang, and D. R. Eyre
COL11A2 Collagen Gene Transcription Is Differentially Regulated by EWS/ERG Sarcoma Fusion Protein and Wild-type ERG
J. Biol. Chem., March 21, 2003; 278(13): 11369 - 11375.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S A Burchill
Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities
J. Clin. Pathol., February 1, 2003; 56(2): 96 - 102.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. H.B. Sorensen, J. C. Lynch, S. J. Qualman, R. Tirabosco, J. F. Lim, H. M. Maurer, J. A. Bridge, W. M. Crist, T. J. Triche, and F. G. Barr
PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children's Oncology Group
J. Clin. Oncol., June 1, 2002; 20(11): 2672 - 2679.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. C. Manara, B. Perbal, S. Benini, R. Strammiello, V. Cerisano, S. Perdichizzi, M. Serra, A. Astolfi, F. Bertoni, J. Alami, et al.
The Expression of ccn3(nov) Gene in Musculoskeletal Tumors
Am. J. Pathol., March 1, 2002; 160(3): 849 - 859.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
E. de Alava and J. Pardo
Ewing Tumor: Tumor Biology and Clinical Applications
International Journal of Surgical Pathology, January 1, 2001; 9(1): 7 - 17.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
E. de Alava, A. Panizo, C. R. Antonescu, A. G. Huvos, F. J. Pardo-Mindan, F. G. Barr, and M. Ladanyi
Association of EWS-FLI1 Type 1 Fusion with Lower Proliferative Rate in Ewing’s Sarcoma
Am. J. Pathol., March 1, 2000; 156(3): 849 - 855.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1999 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online